Taken together, weak or negative HNF3β protein expression was observed in 56.32% (98/174) of colon tumor samples (Figure 1Ae,f), while normal colorectal tissues examined in this study (6 samples) showed strong positive HNF3β staining (Figure 1Aa). This evidence concerns the gene FOXA2 and colonic neoplasm.